Format

Send to

Choose Destination
J Allergy Clin Immunol. 2013 Sep;132(3):584-592.e4. doi: 10.1016/j.jaci.2013.02.003. Epub 2013 Mar 28.

Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.

Author information

1
Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, Fukui, Japan.
2
Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
3
Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
4
Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, Fukui, Japan.
5
Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: rpschleimer@northwestern.edu.

Abstract

BACKGROUND:

Profound edema or formation of a pseudocyst containing plasma proteins is a prominent characteristic of nasal polyps (NP). However, the mechanisms underlying NP retention of plasma proteins in the submucosa remain unclear. Recently, we reported that impairment of fibrinolysis causes excessive fibrin deposition in NP and this might be involved in the retention of plasma proteins. Although the coagulation cascade plays a critical role in fibrin clot formation at extravascular sites, the expression and role of coagulation factors in NP remain unclear.

OBJECTIVE:

The objective of this study was to investigate the expression of coagulation factors in patients with chronic rhinosinusitis (CRS).

METHODS:

Sinonasal tissues were collected from patients with CRS and control subjects. We assayed mRNA for factor XIII-A (FXIII-A) by using real-time PCR and measured FXIII-A protein by means of ELISA, immunohistochemistry, and immunofluorescence.

RESULTS:

FXIII-A mRNA levels were significantly increased in NP tissue from patients with CRS with NP (P < .001) compared with uncinate tissue from patients with CRS or control subjects. Similarly, FXIII-A protein levels were increased in NP. Immunofluorescence analysis revealed that FXIII-A expression in inflammatory cells and FXIII-A(+) cell numbers were significantly increased in NP. Most FXIII-A staining was observed within CD68(+)/CD163(+) M2 macrophages in NP. Levels of FXIII-A correlated with markers of M2 macrophages, suggesting that M2 macrophages are major FXIIIA-producing cells in NP.

CONCLUSION:

Overproduction of FXIII-A by M2 macrophages might contribute to the excessive fibrin deposition in the submucosa of NP, which might contribute to the tissue remodeling and pathogenesis of CRS with NP.

KEYWORDS:

CRS; CRS with nasal polyps; CRS without nasal polyps; CRSsNP; CRSwNP; Chronic rhinosinusitis; FXIII-A; FXIII-B; Factor XIII-A; Factor XIII-B; M2 macrophages; MMR; Macrophage mannose receptor; NP; Nasal polyps; STAB1; Stabilin 1; Tissue plasminogen activator; UT; Uncinate tissue; coagulation cascade; factor XIII-A (FXIII-A); fibrin; nasal polyps; t-PA

PMID:
23541322
PMCID:
PMC3737402
DOI:
10.1016/j.jaci.2013.02.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center